Conclusion

Abstract

This book has covered translational programs in many neurological arenas: neurodegenerative disorders, trauma, stroke, epilepsy, multiple sclerosis, genetic disorders, pain, and cancer. It has addressed techniques central to many translational efforts: genomics, gene therapy, antisense therapy, stem cell therapy, drug discovery/development, bioengineering, and rehabilitation. We have focused on efforts currently in late-stage clinical development or in actual clinical trials; many additional research programs’ efforts also strive to generate sufficiently compelling data to merit human translation.